|Generic Name||Brand Name|
These medicines prevent the formation of blood clots. They can help prevent blood clots in the coronary arteries after a heart attack.
Glycoprotein IIb/IIIa inhibitors might be used with angioplasty after a heart attack. But they are not used for everyone.
Glycoprotein IIb/IIIa inhibitors may help certain people who have angioplasty after a heart attack, such as people who are at high risk for serious blood clots.1
Glycoprotein IIb/IIIa inhibitors are given in the hospital. So a person is watched closely for any side effects.
Bleeding inside the body is the most common side effect.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
Glycoprotein IIb/IIIa inhibitors are only used in the hospital.
- Kushner KG, et al. (2009). 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevated myocardial infarction (Updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (Updating the 2005 guideline and 2007 focused update). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 120(22): 2271–2306.
Last Revised: April 29, 2011
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.